Purinergic receptor-mediated morphological changes in microglia are transient and independent from inflammatory cytokine release

European Journal of Pharmacology
H Beal McIlvainGarth T Whiteside

Abstract

Microglia are commonly described as existing in resting or active states based on morphology or level of cytokine production. Extracellular ATP is a physiologically-relevant activator of microglia, which express a number of purinergic receptors. As P2Y(12) has been linked to chemotaxis, we used a panel of purinergic compounds to understand the role of ATP receptors in morphological transformation and correlate this with TNFalpha production. We quantified activation of cultured microglia with LPS or purinergic receptor agonists by using automated image analysis of cell morphology and CD11b expression and correlated this with TNFalpha release measured by ELISA. Treatment with both ATP and the P2Y(12) receptor agonist, 2-methylthio adenosine diphosphate (2MeSADP), caused a transient increase in CD11b expression (EC(50)=1.2 microM and 187 nM, respectively) and a reduction in process count that reversed within 90 min later. These changes were not accompanied by the release of TNFalpha. Forskolin, IBMX, and pertussis toxin inhibited these changes, but the PLC inhibitor, U73122, did not. 2MeSAMP blocked the ATP response, while AP4A blocked the 2MeSADP response, implicating P2Y(12/13). Microglia activation by LPS also caused an increas...Continue Reading

References

Mar 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·P C ZamecnikG M Blackburn
Feb 3, 1997·The Journal of Experimental Medicine·D FerrariF Di Virgilio
Jul 1, 1997·British Journal of Pharmacology·W NörenbergP Illes
May 26, 1999·Progress in Neurobiology·G Stoll, S Jander
Aug 24, 1999·The Journal of Physiology·S VisentinG Levi
Apr 26, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·J M Sanz, F Di Virgilio
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·R A North, A Surprenant
Aug 11, 2000·Journal of Neurochemistry·I HideY Nakata
Apr 3, 2001·Journal of Neuroimmunology·M A WollmerR Mentlein
Jun 20, 2003·Molecular Pharmacology·Frederic MarteauNathalie Suarez Gonzalez
Jan 13, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Tomohisa SuzukiYoshihiro Nakata
Jun 9, 2004·Biochemical Pharmacology·Marta FumagalliMaria P Abbracchio
Jul 28, 2004·Neuroscience Letters·Kyoungho Suk
Nov 20, 2004·Journal of Thrombosis and Haemostasis : JTH·G KauffensteinC Gachet
Apr 27, 2005·Brain Research. Brain Research Reviews·Katrin Färber, Helmut Kettenmann
Jan 13, 2006·British Journal of Pharmacology·Geoffrey Burnstock
Jun 13, 2006·Pflügers Archiv : European journal of physiology·Tuan TrangMichael W Salter
Jun 23, 2006·Pflügers Archiv : European journal of physiology·Katrin Färber, Helmut Kettenmann
Aug 4, 2006·Nature·Baljit S Khakh, R Alan North
Nov 23, 2006·Nature Neuroscience·Sharon E HaynesDavid Julius
Dec 21, 2006·Nature Reviews. Neuroscience·Michelle L BlockJau-Shyong Hong
Aug 7, 2007·International Review of Neurobiology·Joseph RogersAndrew Grover
May 30, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Tiina M KauppinenRaymond A Swanson
Jul 2, 2008·Nature Reviews. Drug Discovery·Geoffrey Burnstock
Mar 21, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Juana M SanzFrancesco Di Virgilio
Jun 16, 2009·Nature Neuroscience·Anna G OrrStephen F Traynelis

❮ Previous
Next ❯

Citations

Feb 16, 2011·Seminars in Cell & Developmental Biology·Carlos Matute, Fabio Cavaliere
Apr 10, 2015·The Journal of Biological Chemistry·Christian Madry, David Attwell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics (ASM)

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Related Papers

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Mastura MonifDavid A Williams
Pflügers Archiv : European journal of physiology
Katrin Färber, Helmut Kettenmann
© 2021 Meta ULC. All rights reserved